A Glimpse Into The Expert Outlook On HealthEquity Through 13 Analysts
Portfolio Pulse from Benzinga Insights
HealthEquity (NASDAQ:HQY) has received a mix of bullish and somewhat bullish ratings from 13 analysts over the past three months. The average 12-month price target has increased to $101.62, with a high estimate of $110.00 and a low estimate of $92.00. Recent analyst actions include several rating raises and price target increases, reflecting positive sentiment towards the company's financial performance and growth prospects.
June 04, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity has received predominantly bullish ratings from analysts, with an average price target of $101.62. Recent rating raises and price target increases suggest positive sentiment towards the company's financial performance and growth prospects.
The majority of analysts have given bullish ratings, and several have raised their price targets, indicating a positive outlook on HealthEquity's financial performance and growth prospects. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100